Traumatic Brain Injury Assessment & Management Devices Market Size, Share & Trends Report

Traumatic Brain Injury Assessment & Management Devices Market Size, Share & Trends Analysis Report By Device (Imaging, Monitoring), By Technique (ICP, pBrO2), By End Use, By Region, And Segment Forecasts, 2020 - 2027

  • Published Date: Jun, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-4-68038-495-6
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018
  • Number of Pages: 135

Report Overview

The global traumatic brain injury assessment and management devices market size was valued at USD 2.7 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2020 to 2027. Increasing prevalence of traumatic brain injuries (TBIs) and rising awareness regarding brain injuries are the major factors expected to drive the market growth. In addition, the adoption of technologically advanced products and supportive government policies are contributing to market growth.

Germany traumatic brain injuries (TBIs) assessment & management devices market size

TBIs are permanent or temporary impairment to the brain that can be caused by a blow, bump, or shock to the skull. Major causes of TBIs include sports injuries, falls, gunshot wounds, domestic violence, and road traffic accidents. As per the Centers for Disease Control and Prevention (CDC), in the U.S., TBI is responsible for 2.8 million accidents and emergency department visits annually.

Furthermore, according to the Stanford Children’s Health, over 3.5 million sports-related injuries are reported annually among children in the U.S. and around 21% of all are TBIs. Thus, increasing cases of TBIs are anticipated to boost the product demand during the forecast period. Moreover, rise in patient preference for minimally invasive neurosurgeries, due to minimal pain, high efficacy, less chance of infection, and speedy recovery, is expected to boost the market growth.

Currently, most of the TBIs can be primarily handled using minimally invasive devices, such as MRI or CT scanning, transcranial doppler ultrasound, and endoscopy, to remove hematomas or contusions occurred after the brain injury. Such specialized devices make it feasible for the neurosurgeons to reach deep lesions in the brain through a pinhole-sized opening in the skull, without damaging the surrounding tissues.

Furthermore, increasing number of initiatives and programs about TBIs by the governments of various countries is expected to fuel the market growth. For instance, the Brain Injury Association of America (BIAA) as an initiative towards TBIs organizes a national public awareness campaign in the month of March every year to emphasize the importance of acknowledging the impact of brain injuries. The theme for the 2018 to 2020 campaign is ‘Change Your Mind’.

This campaign educates the public about the occurrence of brain injuries and the needs of people with such injuries. The Defense and Veterans Brain Injury Center (DVBIC) offers online education for both civilian and military providers about TBIs to promote the best possible care for service members and veterans around the world. In addition, the CDC has introduced a new educational gaming app, designed to educate 6-8 years old children about basic concussion safety.

This app shows kids how the brain can be injured in different ways during sports activities. Thus, growing awareness among people regarding TBIs and available treatments is likely to boost the TBIs assessment and management devices market growth. Countries, such as the U.S. and Canada, have witnessed high prevalence rate of such injuries due to road accidents, sports injuries, and assaults.

Gunshots or explosive blasts exposure are common cause of TBIs in active-duty military personnel. For instance, as per the DVBIC, between 2000 and late 2019, around 414,000 cases of TBIs have been reported among the U.S. military members. According to the CDC, TBI is a leading cause of death and disability among children and young adults in the U.S.

Device Insights

The imaging devices segment led the market with a share of over 54% in 2019. The imaging devices are further segmented into computed tomography (CT) scan, magnetic resonance imaging (MRI), X-ray, and others. Due to higher sensitivity, imaging devices are widely used to assess patients with mild or severe traumatic brain injury. Thus, increasing applications in the diagnosis and staging of neurological diseases and disorders, particularly TBIs, are expected to fuel the segment growth.

However, monitoring devices segment is expected to register the highest CAGR of 7.6% from 2020 to 2027 owing to minimally invasive nature of these devices. Moreover, increasing demand for non-invasive procedures, preference for brain disease progression monitoring by physicians, and higher accuracy of these devices are expected to drive the segment market growth during the forecast period.

Technique Insights

The ICP monitoring segment dominated the market with a share of 54.8% in 2019. This method is considered as a gold standard for the measurement of accurate increased intracranial pressure in patients with severe brain injury. Several studies have recommended that raised ICP is the common cause of death in patients with TBI. Therefore, continuous ICP monitoring helps in keeping the pressure levels in normal range and provides early and effective treatment options. Thus, advantages offered by ICP monitoring and increasing cases of TBIs are expected to boost the segment growth.

However, partial pressure of oxygen in brain tissue (pBrO2) monitoring segment is expected to register the maximum CAGR of 7.7% from 2020 to 2027. These systems provide continuous monitoring of partial pressure of oxygen in brain tissue, thus, providing early indication of hypoxic events. This is anticipated to increase the demand for pBrO2 monitoring, thereby augmenting segment growth.

End-use Insights

The hospitals segment led the overall market with the share of 43.3% in 2019 owing to the increased prevalence of TBIs across the globe and number of brain surgeries performed in hospitals. Moreover, hospitals are well-equipped with technologically advanced devices, which also supports segment growth. However, the others segment is expected to record the fastest CAGR from 2020 to 2027. This segment includes Ambulatory Surgical Centers (ASCs), research centers, and emergency clinics.

U.S. traumatic brain injuries (TBIs) assessment & management devices market share

The growth of this segment can be attributed to the ongoing advancements in minimally invasive surgical techniques. Moreover, advantages offered by ASCs and emergency clinics, such as inexpensive & shorter procedure time and same-day discharge, will also support segment growth.

Regional Insights

North America led the market with a share of 53.0% in 2019 and will expand further at a significant CAGR from 2020 to 2027. This is attributed to supportive government initiatives, awareness campaigns regarding brain injuries, rising cases of traumatic brain injuries, and presence of well-established healthcare facilities in the region. For instance, as per the CDC, an expected 2.87 million individuals in the U.S. sustain brain injuries and 1.5 million Americans sustain a TBI, annually. Furthermore, availability of technologically advanced products and presence of major key companies, such as Integra LifeSciences, InfraScan, Inc., Advance Brain Monitoring, and Neural Analytics, are contributing to the market growth.

The Asia Pacific region expected to register the highest CAGR of 8.9% from 2020 to 2027. This is due to the factors, such as the rising geriatric population, rise in the number of people suffering from TBIs, and increasing incidence of road accidents. For instance, according to the Ministry of Road Transport and Highways, Government of India, in 2016, around 4, 94, 624 people were injured in road accidents. This number has increased by 25.6% from 2007 to 2017. Moreover, improved quality of diagnosis and growing patient affordability have together resulted in regional market growth. In addition, high growth opportunities in developing countries, such as Japan, India, and China, are likely to contribute to market growth.

Latin America is expected to gain significant market share as there is an improvement in the healthcare facilities and medical device sector. This is due to the increasing healthcare expenditure in most of the Latin American countries, especially in Brazil. Thus, providing ample growth opportunities to the players operating in the global market. For instance, according to the WHO, in 2016, Brazil’s healthcare expenditure as a proportion of GDP was 8.5%, Argentina accounted for 4.2%, Mexico accounted for 6.5%, and Chile’s spending was 8.3%. Moreover, according to a report published by the NCBI in 2018, Brazil has witnessed improvements and developments in treatments and has better access to technology and education. This is expected to significantly cater to market growth during the forecast period.

Key Companies & Market Share Insights

Companies are stressing on R&D to develop technologically advanced products to gain a competitive edge. For instance, in January 2019, Oculogica Inc, has received the US FDA request for marketing of EyeBOX device. This device uses eye-tracking to help in the diagnosis of patients with suspected concussions in 4-minute test.

In February 2019, the U.S. FDA granted breakthrough device designation to the BioDirection’s NanoDx System to measure the body’s response to brain trauma. This system predicts positive Computerized Tomography (CT) scans after traumatic brain injury.

In June 2019, Nihon Kohden launched wireless Electroencephalogram (EEG) headset called VitalEEG to promptly assess brain activity in unconscious patients. In addition, BrainScope was granted over USD 32 million from the U.S. Department of Defense for the development of its BrainScope One device, an EEG-based non-invasive technology.

Companies are also focusing on business strategies, such as M&A and partnerships, to strengthen their market reach & product portfolio and to increase manufacturing capacities. For instance, in September 2019, Integra LifeSciences completed the acquisition of Rebound Therapeutics for novel product development. Some of the prominent players in the traumatic brain injury assessment and management devices market include:

  • Integra Lifesciences

  • BioDirection, Inc.

  • Nihon Kohden Corporation

  • Compumedics Ltd.

  • InfraScan, Inc.

  • Oculogica

  • Raumedic AG

Traumatic Brain Injury Assessment & Management Devices Market Report Scope

Report Attribute


Market size value in 2020

USD 2.9 Billion

Revenue forecast in 2027

USD 4.7 Billion

Growth rate

CAGR of 7.3% from 2020 to 2027

Base year for estimation


Historical data

2016 - 2018

Forecast period

2020 - 2027

Quantitative units

Revenue in USD million and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Device, technique, end use, region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, Colombia, South Africa, Saudi Arabia, UAE

Key companies profiled

BioDirection, Inc.; BrainScope Company, Inc.; Neural Analytics, Inc.; Compumedics Ltd.; Integra LifeSciences; InfraScan, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global traumatic brain injury assessment and management devices market report on the basis of device, technique, end use, and region:

  • Device Outlook (Revenue USD Million; 2016 - 2027)

    • Imaging Devices

    • Monitoring Devices

  • Technique Outlook (Revenue USD Million; 2016 - 2027)

    • Intracranial Pressure (ICP) Monitoring

    • Partial Pressure of Oxygen In Brain Tissue (pBrO2)

  • End Use Outlook (Revenue USD Million; 2016 - 2027)

    • Hospitals

    • Diagnostic Centers

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2027)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The UK

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities